Matches in Wikidata for { <http://www.wikidata.org/entity/Q91913828> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91913828 description "article scientifique publié en 2020" @default.
- Q91913828 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91913828 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91913828 description "scientific article published on 14 April 2020" @default.
- Q91913828 description "wetenschappelijk artikel" @default.
- Q91913828 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q91913828 name "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 name "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 type Item @default.
- Q91913828 label "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 label "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 prefLabel "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 prefLabel "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 P1433 Q91913828-56A44D5A-70AF-4D7F-A709-71A66AEBAEE8 @default.
- Q91913828 P1476 Q91913828-B7D46736-35C6-4E8D-99F4-DEE38B0635AE @default.
- Q91913828 P2093 Q91913828-5274830A-520C-4C28-B5F1-F90FDC4EC564 @default.
- Q91913828 P2093 Q91913828-6F29ECA2-C04B-40CC-B6FD-52D354792711 @default.
- Q91913828 P2093 Q91913828-9185C9F7-E42C-4B1A-8279-4233159DA003 @default.
- Q91913828 P2093 Q91913828-BFC797BA-F9CD-488A-B862-F934A5D1225A @default.
- Q91913828 P2093 Q91913828-D1A615B5-E42F-4CAF-A080-F42B097591C8 @default.
- Q91913828 P2093 Q91913828-D6AB8BA6-723C-4CC0-AA6D-F8DA9D45699E @default.
- Q91913828 P31 Q91913828-240C1647-F723-4ABF-A847-F578E15C05EE @default.
- Q91913828 P356 Q91913828-00031F4D-179C-4A45-97C2-D7CC48FE4BAD @default.
- Q91913828 P577 Q91913828-2076A8DC-EC3D-420A-833A-A95AE0155E16 @default.
- Q91913828 P698 Q91913828-8D4F729D-54B6-477A-8EF9-07E0146B5F61 @default.
- Q91913828 P921 Q91913828-7E4B980B-F6AE-4D3E-95E7-34EEA073EBB7 @default.
- Q91913828 P921 Q91913828-DA752637-B563-4CAC-85FE-D1C5B49DE367 @default.
- Q91913828 P932 Q91913828-5004ACE5-03E5-4BA2-A82B-FD24CEC26712 @default.
- Q91913828 P356 EJH.13427 @default.
- Q91913828 P698 32289184 @default.
- Q91913828 P1433 Q15765799 @default.
- Q91913828 P1476 "Cost-Effectiveness of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-cell acute Lymphoblastic Leukemia" @default.
- Q91913828 P2093 "A van Dongen-Leunis" @default.
- Q91913828 P2093 "Amm Arons" @default.
- Q91913828 P2093 "C A Uyl-de Groot" @default.
- Q91913828 P2093 "F W Thielen" @default.
- Q91913828 P2093 "J R Ladestein" @default.
- Q91913828 P2093 "P M Hoogerbrugge" @default.
- Q91913828 P31 Q13442814 @default.
- Q91913828 P356 "10.1111/EJH.13427" @default.
- Q91913828 P577 "2020-04-14T00:00:00Z" @default.
- Q91913828 P698 "32289184" @default.
- Q91913828 P921 Q102293395 @default.
- Q91913828 P921 Q18553852 @default.
- Q91913828 P932 "7497258" @default.